Characterization of IGFBP-3, PAI-1 and SPARC mRNA expression in senescent fibroblasts

Mechanisms of Ageing and Development

Volumn 92, Issue 2-3, 1996, Pages 121-132

  Wang, Sandia ^a,b   Moerman, Elena J ^a   Jones, Richard A ^a   Thweatt, Ray ^a,c   Goldstein, Samuel ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Department of Epithelial Biology   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Cellular senescence; Gene expression; IGFBP 3; PAI 1; SPARC

Indexed keywords

MESSENGER RNA; OSTEONECTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; ATHEROSCLEROSIS; CELL GROWTH; CONTROLLED STUDY; DIPLOIDY; DNA SYNTHESIS; FIBROBLAST; FIBROBLAST CULTURE; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; PRIORITY JOURNAL; RNA DEGRADATION; SENESCENCE;

EID: 0030595971     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(96)01814-3     Document Type: Article

References (45)

1. [1] L. Hayflick, The limited in vitro lifetime of human diploid cell strains. Expt. Cell Res., 37 (1965) 614-636.
2. [2] S. Goldstein, Replicative senescence: the human fibroblasts comes of age. Science, 249 (1990) 1129-1133.
3. [3] T.H. Norwood, J.R. Smith and G.H. Stein, Aging at the cellular level: The human fibroblastlike cell model. In: E.L. Schneider and J.W. Rowe (eds.), Handbook of the Biology of Aging, Academic Press, San Diego, CA, 1990, pp. 131-154.
4. [4] V.J. Cristofalo and R.J. Pignolo, Replicative senescence of human fibroblast-like cells in culture. Physiol. Rev., 73 (1993) 617-638.
5. [5] C.J. Epstein, G.M. Martin, A.L. Schultz and A.G. Motulsky, Werner syndrome. A review of its symptomology, natural history, pathological features, genetics and relationship to the natural aging process. Medicine, 45 (1966) 177-221.
6. [6] S. Goldstein, Cellular senescence. In: L.J. DeGroot, L. Martini, J. Potts, D. Nelson, A. Winegrad, W. Odell and G. Cahill (Eds.) Endocrinology, Vol. 3, Grune and Stratton, New York, 1989, pp. 2525-2549.
7. [7] K.T. Tanaka, Y. Nakazawa, Y. Okada and Y. Kumahara, Roles of nuclear and cytoplasmic environments in the retarded DNA synthesis in Werner syndrome cells. Expt. Cell Res., 127 (1980) 185-190.
8. [8] C.K. Lumpkin, Jr., J.K. McClung, O.M. Pereira-Smith and J.R. Smith, Existence of high abundance antiproliferative mRNA's in senescent human dipliod fibroblasts. Science, 232 (1986) 393-395.
9. [9] S. Murano, R. Thweatt, R.J. Shmookler-Reis, R.A. Jones, E.J. Moerman and S. Goldstein, Diverse gene sequences are overexpressed in Werner syndrome fibroblasts undergoing premature replicative senescence. Mol. Cell. Biol., 11 (1991) 3905-3914.
10. [10] R. Thweatt and S. Goldstein, Werner syndrome and biological aging: A molecular genetic hypothesis. Bioessays, 15 (1993) 421-426.
11. [11] J.S.M. DeMellow and R.C. Baxter, Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem. Biophys. Res. Comm., 156 (1988) 199-204.
12. [12] E.J. Moerman, R. Thweatt, A.M. Moerman, R.A. Jones and S. Goldstein, Insulin-like growth factor binding protein-3 is overexpressed in senescent and quiescent human fibroblasts. Exp. Gerontol., 28 (1993) 361-370.
13. [13] S.E. Funk and E.H. Sage, Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts. J. Cell. Physiol., 154 (1993) 53-63.
14. [14] Q. Maulders, C.J. He, C. Adida, M.N. Peralsi, W.D. Schleuning, J.D. Sraar and E. Rondeau, TNF-α increases antifibrinolytic activity of cultured human mesangial cells. Kidney Intern., 42 (1992) 327-334.
15. [15] E.J. Moerman and S. Goldstein, Culture of human skin fibroblasts. In: W.L. Clarke, J. Larner and S.L. Pohl (eds.) Methods in Diabetes Research, Vol. 2, Wiley, New York, 1986, pp. 283-312.
16. [16] P. Chomczynski and N. Sacchi, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162 (1987) 156-159.
17. [17] P.S. Zelenka, L.A. Pallansch and M. Vatal, Nuclear run-on transcription from primary embryonic lens tissue. Dev. Biol., 132 (1989) 69-72.
18. [18] K.K. Srivatava, E.E. Cable and H.L. Bonkovsky, Purifying nascent mRNA from nuclear run-on assays using guanidinium isothiocyanate. Biotechniques, 15 (1993) 226-227.
19. [19] S. Dalton, Cell cycle regulation of the human cdc-2 gene. EMBO J., 11 (1992) 1797-1804.
20. [20] T. Seshadri and J. Campisi, Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts. Science, 247 (1990) 205-209.
21. [21] S. Harrold, C. Genovese, B. Kobrin, S.L. Morrison and C. Milcarek, A comparison of apparent mRNA half-life using kinetic labeling techniques vs. decay following administration of transcriptional inhibitors. Anal. Biochem., 198 (1991) 19-29.
22. [22] B.T. Kren, N.M. Kumar, S.Q. Wang, N.B. Gilula and C.J. Steer, Differential regulation of multiple gap junction transcripts and protein during rat liver regeneration. J. Cell. Biol., 123 (1992) 707-718.
23. [23] M. Shetty, N. Ismail-Beigi, J.N. Loeb and F. Ismail-Beigi, Induction of GLT1 mRNA in response to inhibition of oxidative phosphorylation. Am. J. Physiol., 265 (1993) 1224-1229.
24. [24] A. Swaroop, B.L.M. Hogan and U. Francke, Molecular analysis of the cDNA for human SPARC/osteonectin/BM40: Sequence, expression, and localization of the gene to chromosome 5q31-q33. Genomics, 2 (1988) 37-47.
25. [25] D. Ginsburg, R. Zeheb, A.Y. Yang, U.M. Rafferty, P.A. Andreasen, L. Nielsen, K. Dano, R.V. Lebo and T.D. Gelehrter, cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. J. Clin. Invest., 78 (1986) 1673-1680.
26. [26] R. Thweatt, R. Fleischmann and S. Goldstein, Analysis of the primary structure of insulin-like growth factor binding protein-3 cDNA from Werner syndrome fibroblasts. DNA Sequence, 4 (1993) 43-46.
27. [27] P. Ponte, S.Y. Ng, J. Engel, P. Gunning and L. Kedes, Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucl. Acids Res., 12 (1984) 1687-1696.
28. [28] V.G. Grigoriev, E.J. Moerman, and S. Goldstein, Overexpression of insulinlike growth factor binding protein-3 by senescent human fibroblasts: Attenuation of the mitogenic response to IGF-1. Expt. Cell Res., 219 (1995) 315-321.
29. [29] S. Goldstein, E.J. Moerman and R.C. Baxter, Accumulation of insulin-like growth factor binding protein-3 in conditioned medium of human fibroblasts increases with chronological age of donor and senescence in vitro. J. Cell. Physiol., 156 (1993) 294-302.
30. [30] S. Goldstein, E.J. Moerman, S. Fujii and B.E. Sobel, Overexpression of plasminogen activator inhibitor type-1 in senescent fibroblasts from normal subjects and those with Werner syndrome. J. Cell. Physiol., 161 (1994) 571-579.
31. [31] G. DePetro, A. Copeta and S. Barlati, Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. Exp. Cell Res., 213 (1994) 286-294.
32. [32] P.M. Tremble, T.F. Lane, E.H. Sage and Z. Werb, SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteases in fibroblasts through a novel extracellular matrix-dependent pathway. J. Cell Biol., 121 (1993) 1433-1444.
33. [33] J.D. Parvin, H.T. Timmers and P.A. Sharp, Promoter specificity of basal transcription factors. Cell, 68 (1992) 1135-1144.
34. [34] G. Gill and R. Tjian, Eukaryotic coactivators associated with the TATA box binding protein. Current Opinions Genet. Dev., 2 (1992) 236-242.
35. [35] J.H. Albrecht, J.S. Hoffman, B.T. Kren and C.J. Steer, Cyclin and cyclin-dependent kinase 1 mRNA expression in models of regeneration liver and human liver diseases. Am. J. Physiol., 265 (1993) 857-864.
36. [36] A.B. Sachs, Messenger RNA degradation in eukaryotes. Cell, 74 (1993) 413-421.
37. [37] J.T. Wrana, T. Kubota, Q. Zhang, C.M. Overall, J.E. Aubin, W.T. Butler and J. Sodek, Regulation of transformation-sensitive secreted phosphoprotein (SPPI/osteopontin) expression by transforming growth factor beta. Biochem. J., 273 (1993) 523-531.
38. [38] V. Shalhooub, L.C. Gerstenfeld, D. Collart, J.B. Lian, and G.S. Stein, Downregulation of cell growth and cell cycle regulated genes during chick osteoblast differentiation with the reciprocal expression of histone gene variants. Biochemistry, 28 (1989) 5318-5322.
39. [39] M.S. Kindy, K.E. Brown and G.E. Sonenshein, Regulation of expression of the growth-state-related genes 2F1 and 2A9 during entry of quiescent smooth muscle cells into the cell cycle. J. Cell. Biochem., 46 (1991) 345-350.
40. [40] D.E. Dobson, D.L. Groves and B.M. Spiegelman, Nucleotide sequence and hormonal regulation of mouse glycerophosphate dehydrogenase mRNA during adipocytes and muscle cell differentiation. J. Biol. Chem., 262 (1987) 1804-1809.
41. [41] J.M. Leiden, Transcription regulation of TCR genes. Ann. Rev. Immunol., 11 (1993) 539-570.
42. [42] H.M. Jack and M. Wabl, Immunoglobulin mRNA stability varies during B lymphocyte differentiation. EMBO J., 7 (1988) 1041-1046.
43. [43] C.D. Chang, P. Phillips, K.E. Lipson, V.J. Cristofalo and R. Baserga, Senescent human fibroblasts have a posttranscriptional block in the expression of the PCNA gene. J. Biol. Chem., 266 (1991) 8663-8666.
44. [44] Q. Hu, E.J. Moerman and S. Goldstein, Altered expression and regulation of the α5β1 integringfibronectin receptor leads to reduced amounts of functional α5β1 heterodimer on the plasma membrane of senescent human diploid fibroblasts. Exp. Cell Res., 224 (1996) in press.
45. [45] J.T. Wrana, C.M. Overall and J. Sodek, Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor beta. Eur. J. Biochem., 197 (1991) 519-528.